Keryx Biopharmaceuticals

NASDAQ: KERX
$3.36
-$0.07 (-2.0%)
Closing price December 12, 2018
These are the top analyst upgrades and downgrades covered by 24/7 Wall St. for Monday, September 8, 2014.
Source: ThinkstockKeryx Biopharmaceuticals Inc. (NASDAQ: KERX) announced on Friday that it had received approval from the FDA on its most recent drug Ferric Citrate, formerly known as Zerenex. The...
The Quantitative Strategies team at Jefferies closely monitors the index changes. 24/7 Wall St. screened the Jefferies list of stocks that will see major position adds for the rebalance. Some of them...
The team at Oppenheimer has a list of biotech stocks to buy that feature catalysts that could be game changers. They all have 50% or higher upside to the firm's price target.
Source: ThinkstockBiotech and certain aspects of the health care and life sciences sector can often see incredible surges from day to day. The group can also witness many implosions on bad news as...
Investors and traders are often on the hunt for fresh research ideas that will lead to higher income or more profits in this choppy stock and volatile market. 24/7 Wall St. reviews many fresh...
Source: ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as a U.S. Food and Drug Administration (FDA) approval or a life-saving capital raise is the...
Investors and traders alike always seem to be on the lookout for new speculative investment ideas that can generate massive long-term or short-term gains. While investors get to see many Buy ratings...
Source: ThinkstockBiotech investing has always proven to be a slippery slope. It is one thing to own one of the large-cap biotech stocks, but it can be a challenge when looking for the stocks that...
U.S. equity markets opened higher this morning on the heels of a solid report on U.S. nonfarm payrolls, which rose less than expected but on top of a large upward revision for December (more coverage...
U.S. equity markets opened slightly lower this morning following not-much in the way of new data and a wait-and-see attitude until tomorrow’s meeting announcement from the FOMC, which began a...
Source: Photo by Spencer Platt/Getty ImagesThe stock market is mixed Tuesday, with the Dow Jones Industrial Average up 0.27%, the Nasdaq down 0.35% and the S&P 500 up 0.13%. Today’s winners are a...
U.S. equity markets opened mixed this morning on relatively little new data. In Europe, Italian consumer confidence rose more than expected and Germany auctioned 12-month bills at a positive yield...
Source: ThinkstockKeryx Biopharmaceuticals Inc. (NASDAQ: KERX) has not been a household name in biotech investing, but the move on news on Monday has put the company on the map. After shares are up...
The stock market is down Monday, with the Dow Jones Industrial Average down 0.20%, the Nasdaq down 0.04% and the S&P 500 down 0.39%. Today’s sole winner is a pharmaceutical company with a kidney...